NGS Based RNA Seq Market 2027 By Product, Distribution Channel, Technology, Key Manufacturers

NGS-Based RNA-Sequencing Market to 2027 - Global Analysis and Forecasts By Product & Services (Sample Preparation, Sequencing Services, Sequencing Platform & Consumables and Data Analysis, Storage & Management), Technology (Sequencing by Synthesis, Nanopore Sequencing, Ion Semiconductor Sequencing and Single Molecule Real Time Sequencing), Application (Diagnostics, Drug Discovery, Precision Medicine and Others), End User (Biotechnology & Pharmaceutical Companies, Hospitals & Clinics, Research Centers and Academic & Government Institutes and Others ) and Geography

Publication Month : Jan 2019

  • Report Code : TIPBT00002556
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 205
Inquire Before Buy

PRICING

$4550

$2730

The NGS-based RNA seq market was valued at US$ 1,414.59 million in 2018 and it is projected to reach US$ 7,984.90 million in 2027; it is expected to grow at a CAGR of 19.3% from 2018 to 2027.

The NGS based RNA seq is done without a reference sequence for the strand-specific libraries that are being profiled for the rare and novel therapeutics. It is highly revolutionized study of the transcriptome which is highly sensitive and accurate for the measurement of the expression all over the transcriptome. The NGS based RNA seq provides researchers with visibility for previously undetected changes occurring in disease states, in response to therapeutics caused by different environmental conditions. In addition, this technique enables researchers to detect the known and unknown features in single assay. Moreover it assists in detecting the gene fusions, single nucleotide variants, transcript isoforms and other features without the restriction of prior data. The growth of the global NGS-based RNA seq market is attributed to the reduced cost of genome sequencing, advancements in sequencing technology and next generation sequencing for cancer. However, risks related to genetic data and high cost of NGS instruments are the major factor hindering the market growth.

The global NGS-based RNA seq market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

Lucrative Regions for Global NGS-Based RNA Seq Market



Lucrative Regions for Global NGS-Based RNA Seq Market
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Market Insights

Reduced Cost of Genome Sequencing to Drive Global NGS-Based RNA Seq Market Growth

The growth in the adoption of the next generation sequencing is rising, recently in few years, next generation sequencing price have reduced greatly. For instance, first whole human genome sequencing cost over US$ 3billion in 2001 and it took approximately 15 years for its completion. However, the costs for the same in recent years has reduced to US$1,000 and the process requires less number of days. The cost of sequencing was approximately US$ 3 billion, which dropped down to US$ 10 million in 2006 and as the development in the technologies has increased the prices of sequencing has decreased to US$ 5,000 in 2012. Major market players such as Illumina and Hoffman La Roche Ltd have introduced breakthrough technologies that have enabled in the cost and time reduction in the sequencing.

Moreover, the increase in the service provider companies in the market and their offering for next generation sequencing are cheaper. For instance, Applied Biological Materials, Inc. is an Illumina Certified Service Provider, which offer the next generation sequencing in low cost. Services such as single-end total RNA Sequencing (8 million reads, 1x75bp SE) with minimum two samples is offered in US $375. Likewise paired-end total-end sequencing (8 Million reads, 2x75bp PE) with two samples is performed in US$ 445. Whereas, miRNA seq/Small RNA sequencing (10 million, 1x75 SE) with two samples is offered in US$ 645.

Hence, considering these factors such as advances in the field of next generation sequencing, development in different methods and strategies for sequencing, notable decline in the cost of sequencing, increase in the next generation sequencing service providers are likely to propel the growth of the NGS based RNA seq.


Product & Services -Based Insights

In terms of product & services, the global NGS-based RNA seq market is segmented into sample preparation, sequencing services, sequencing platforms & consumables and data analysis, storage & management. In 2018, the sequencing platforms & consumables segment held largest share of the market. However, the data analysis, storage & management segment is estimated to register the highest CAGR during the forecast period.

Global NGS-Based RNA Seq Market, by Product & Services – 2018 and 2027



Global NGS-Based RNA Seq Market, by Product & Services – 2018 and 2027
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Technology -Based Insights

Based on technology, the global NGS-based RNA seq market is segmented into sequencing by synthesis (SBS), nanopore sequencing, ion semiconductor sequencing and single-molecule real-time (SMRT) sequencing. The sequencing by synthesis segment held the largest market share in 2018, also the same segment is estimated to grow at the fastest rate during the forecast period.

Application-Based Insights

In terms of application, the global NGS-based RNA seq market is segmented into diagnostics, drug discovery, precision medicine and others. In 2018, the diagnostics segment held largest share of the market. The same segment is expected to register the highest CAGR during the forecast period.

End User-Based Insights

In terms of end user, the global NGS-based RNA seq market is segmented into hospitals & clinics, academic & research institutes, pharmaceutical & biotechnology companies and other. The academic & research institutes segment held the largest share of the market in 2018, and the hospitals & clinics segment is estimated to register the highest CAGR during the forecast period.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

NGS-Based RNA-Sequencing Market: Strategic Insights

ngs-based-rna-seq-market
Market Size Value inUS$ 1,414.59 Million in 2018
Market Size Value byUS$ 7,984.90 Million by 2027
Growth rateCAGR of 19.3% from 2019-2027
Forecast Period2019-2027
Base Year2019
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

The global NGS-based RNA seq market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

Global NGS-Based RNA Seq Market – by Product & Services

  • Sample Preparation
  • Method
  • Manual Method
  • Automated Method
  • Workflow Step
  • Library Preparation & Target Enrichment
  • Fragmentation, End Repair & Size Selection
  • Quality Control
  • Sequencing Services
  • Sequencing Platform & Consumables
  • Data Analysis, Storage & Management

Global NGS-Based RNA Seq Market – by Technology

  • Sequencing By Synthesis
  • Nanopore Sequencing
  • Ion Semiconductor Sequencing
  • Single-Molecule Real-Time (SMRT) Sequencing

Global NGS-Based RNA Seq Market – by Application

  • Diagnostics
  • Drug Discovery
  • Precision Medicine
  • Others

Global NGS-Based RNA Seq Market – by End- User

  • Hospitals & Clinics
  • Research Centers and Academic & Government Institutes
  • Biotechnology & Pharmaceutical Companies
  • Others

Global NGS-Based RNA Seq Market – by Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South America and Central America (SCAM)

    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • Thermo Fisher Scientific Inc.
  • Illumina Inc.
  • Pacific Biosciences of California, Inc.
  • F. Hoffman-La Roche Ltd
  • Agilent Technologies
  • BGI
  • Oxford Nanopre Technologies
  • Eurofins Scientific
  • Qiagen
  • Perkinelmer Inc.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product & Services , Technology , Application , End User and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina

The List of Companies

1. Illumina, Inc.
2. Thermo Fisher Scientific Inc.
3. Pacific Biosciences of California, Inc.
4. Qaigen
5. F. Hoffmann-La Roche AG
6. Agilent Technologies, Inc.
7. BGI
8. Oxford Nanopore Technologies
9. Perkinelmer, Inc.
10. Eurofins Scientific

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to NGS-Based RNA-Sequencing Market